title: No effect of PGI2 and TXB2 on the proliferation of immature forms of leukemic blasts.
authors.forename: Rémi
authors.initials: R
authors.lastname: Fiancette
authors.forename: Christelle
authors.initials: C
authors.lastname: Vincent
authors.forename: Magali
authors.initials: M
authors.lastname: Donnard
authors.forename: Pascal
authors.initials: P
authors.lastname: Turlure
authors.forename: Dominique
authors.initials: D
authors.lastname: Bordessoule
authors.forename: Franck
authors.initials: F
authors.lastname: Trimoreau
authors.forename: Yves
authors.initials: Y
authors.lastname: Denizot
mesh_terms: D049109:Cell Proliferation / Q000187:drug effects*; D011464:Epoprostenol / Q000494:pharmacology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000378:metabolism*; D044006:Receptors, Epoprostenol / Q000096:biosynthesis; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000096:biosynthesis; D013928:Thromboxane A2 / Q000494:pharmacology*
chemical_list: D044006:Receptors, Epoprostenol; D044244:Receptors, Thromboxane A2, Prostaglandin H2; D013928:Thromboxane A2; D011464:Epoprostenol